Oncternal Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '25 Aug 11, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023
Market Capitalization	8	6	-	-
Enterprise Value	8	5	-	-
Last Close Price	0.14	0.11	-	-
PB Ratio	4.13	2.57	-	-
P/TBV Ratio	4.84	2.97	-	-
Debt / Equity Ratio	0.01	0.01	-	-
Quick Ratio	0.60	1.31	3.68	23.90
Current Ratio	0.60	1.34	5.23	23.90
Return on Equity (ROE)	-40.72%	-234.77%	-118.24%	-
Return on Assets (ROA)	-16.54%	-14.74%	-72.57%	-
Return on Capital (ROIC)	-18.91%	-15.98%	-76.41%	-
Earnings Yield	-11.89%	-111.77%	-	-
FCF Yield	-2.34%	-6.29%	-	-
Buyback Yield / Dilution	-75.40%	-80.44%	-50.39%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.